BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17274947)

  • 21. Loss of CDC4/FBXW7 in gastric carcinoma.
    Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
    Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC is a critical target of FBXW7.
    Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
    Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
    Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
    Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fbw7 isoform interaction contributes to cyclin E proteolysis.
    Zhang W; Koepp DM
    Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
    Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
    Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
    Zhao J; Wang Y; Mu C; Xu Y; Sang J
    Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma].
    Zhou ZY; Tu KS; Zhang J; Zheng X; Gao J; Yao YM; Liu QG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1303-6. PubMed ID: 23232523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the ubiquitin ligase Fbw7 in cancer progression.
    Cheng Y; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
    Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
    Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
    Guo Z; Zhou Y; Evers BM; Wang Q
    Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
    Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
    Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
    Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBXW7 and DNA copy number instability.
    Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
    Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.
    Davis H; Lewis A; Behrens A; Tomlinson I
    Gut; 2014 May; 63(5):792-9. PubMed ID: 23676439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
    Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
    Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.